A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
Body unavailable. Use the original source.
A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline